Acorda Therapeutics, Inc. (ACOR): Price and Financial Metrics
Acorda Therapeutics, Inc. (ACOR)
Today's Latest Price: $1.76 USD
0.08 (-4.35%)
Updated Dec 13 12:00am
Add ACOR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ACOR Stock Summary
- With a price/sales ratio of 0.31, Acorda Therapeutics Inc has a higher such ratio than only 10.9% of stocks in our set.
- Revenue growth over the past 12 months for Acorda Therapeutics Inc comes in at -48.01%, a number that bests merely 3.71% of the US stocks we're tracking.
- The volatility of Acorda Therapeutics Inc's share price is greater than that of 97.77% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to ACOR, based on their financial statements, market capitalization, and price volatility, are QUMU, XONE, ICAD, DOMO, and MRIN.
- ACOR's SEC filings can be seen here. And to visit Acorda Therapeutics Inc's official web site, go to www.acorda.com.
ACOR Daily Price Range
ACOR 52-Week Price Range
ACOR Stock Price Chart More Charts
ACOR Price/Volume Stats
| Current price | $1.76 | 52-week high | $17.57 |
| Prev. close | $1.84 | 52-week low | $1.49 |
| Day low | $1.74 | Volume | 1,161,100 |
| Day high | $1.92 | Avg. volume | 1,249,714 |
| 50-day MA | $2.09 | Dividend yield | N/A |
| 200-day MA | $6.62 | Market Cap | 84.53M |
Acorda Therapeutics, Inc. (ACOR) Company Bio
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The company was founded in 1995 and is based in Ardsley, New York.
Top Stories View All
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
Best & Worst Performing Mega Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...